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Abstract 
Infection with the SARS-CoV-2 virus affects a wide range of systems. Significant involvement of the central nerv-
ous system has been described, including ischemic and hemorrhagic strokes. Thus far, neuropathologic reports 
of patients who passed away from COVID-19 have generally described non-specific findings, such as variable 
reactive gliosis and meningeal chronic inflammatory infiltrates, as well as the consequences of the infection’s 
systemic complications on the brain, including ischemic infarcts and hypoxic/ischemic encephalopathy. The neu-
ropathological changes in patients with COVID-19 and large hemorrhagic strokes have not been described in 
detail. We report the case of an elderly male who had a long course of COVID-19 and ultimately passed away 
from a large intracerebral hemorrhage. In addition to acute hemorrhage, neuropathologic examination demon-
strated non-specific reactive changes and chronic periventricular lesions with macrophagic and perivascular lym-
phocytic infiltrates without evidence of demyelination or presence of SARS-CoV-2 by PCR test. This manuscript 
expands the spectrum of reported neuropathological changes in patients with COVID-19. 
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Intracerebral hemorrhage (ICH) is an uncom-
mon complication of infection with severe acute res-
piratory syndrome coronavirus 2 (SARS-CoV-2) virus, 
affecting 0.5-7.9% of patients hospitalized with 
COVID-191–3. Therapeutic anticoagulation has been 
identified as the most common etiology1–3 and an 
important risk factor for ICH in COVID-194. In addi-
tion, other factors such as micro- and macrovascular 
thrombosis, endothelial dysfunction and endo-
theliitis may play important pathogenic roles in this 
setting. Despite this plethora of hypothesized fac-
tors, only a few neuropathological reports have in-
cluded detailed histopathological brain evaluations 
of COVID-19 patients with large fatal ICH. 
Post-mortem neuropathological evaluation of 
patients with COVID-19 have shown a range of his-
tological changes and have been reviewed else-
where5,6. The vast majority of cases show relatively 
mild and non-specific findings including variable and 
diffuse micro- and astrogliosis, and mild parenchy-
mal and leptomeningeal infiltration by chronic in-
flammatory infiltrates, which could represent the 
histological features of an encephalopathy associ-
ated with severe systemic inflammation rather than 
specific COVID-19-related changes7. In addition, 
many cases show variable hypoxic-ischemic enceph-
alopathy, infarcts associated with large vessel 
thromboembolism and variable hemorrhagic lesions 
from microhemorrhages to fatal ICH5,6. 
Only three detailed neuropathological reports 
of patients with large ICH have been published to 
date and include a case of cerebellar hemorrhage 
thought to be most likely secondary to hypertensive 
vasculopathy8, one of hemorrhagic transformation 
of a large middle cerebral artery stroke9 and two 
cases reported by the authors as ICH in the context 
of lymphocytic panencephalitis, meningitis and dif-
fuse petechial hemorrhages10. In the latter, no de-
tails are provided regarding the histological changes 
associated with, or the etiopathogenesis of, the ICH 
or petechial hemorrhages. 
In this report, we expand on the neuropatho-
logical literature of COVID-19 cases by detailing the 
neuropathological findings in an elderly male with 
COVID-19 and fatal ICH. Some of the findings re-
ported in this case were also seen in a younger indi-
vidual with COVID-19 and fatal ICH for which we 
were unable to acquire consent for publication of 
clinical details. The histological similarities and dif-
ferences between these two cases will be high-
lighted in the text. 
Case presentation 
This male patient, in his early 70s, presented to 
hospital with bilateral pneumonia secondary to 
COVID-19 infection that was confirmed by nasopha-
ryngeal swab testing. Parallel testing for Influenza A, 
B and Respiratory Syncytial Virus were negative. His 
prior medical history included hypertension and sig-
nificant hip osteoarthritis. He was diagnosed with 
septic shock and transferred to the Intensive Care 
Unit upon admission as he required vasopressors 
and mechanical ventilation. His mean arterial pres-
sure was targeted to more than 65 mmHg while his 
systolic blood pressure (SBP) was kept below a ceil-
ing of 180 to 200 mmHg to avoid ischemic brain in-
jury. This was especially relevant in the context of his 
shock syndrome and prior history of hypertension. 
Only two SBP episodes over 180 mmHg, both of less 
than 30 min in duration, were recorded 4 and 19 
days prior to his terminal ICH. 
During his first week of admission, he devel-
oped renal failure, which was thought clinically sec-
ondary to acute tubular necrosis in the context of 
multisystem organ failure. He was placed on contin-
uous renal replacement therapy (CRRT) one week 
after admission. This required local anticoagulation 
with unfractionated heparin titrated to obtain an ac-
tivated partial thromboplastin time (aPTT) post-
CRRT filter of 60 to 90 seconds. His international nor-
malized ratio (INR) hovered around the upper nor-
mal limit of 1.2 during his entire hospitalization. 
Other relevant laboratory findings included an ele-
vated d-dimer, C reactive protein and procalcitonin. 
He did not have evidence of pulmonary embolism 
during his hospitalization. 
Nearly three weeks into his admission and two 
weeks after initiation of CRRT, the patient showed 
evidence of decreased level of consciousness. A 
computerized tomography scan demonstrated a left 
frontal intracerebral hemorrhage with intraventric-
ular extension and subfalcine herniation (Fig. 1A). 
He died the next day after withdrawal of life-sustain- 
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Figure 1. (A) CT scan showed a large left frontal ICH with intraventricular extension. (B) Coronal sections confirmed this ICH and left-to-
right subfalcine herniation. (C) Leptomeningeal chronic inflammatory infiltrates were most prominent in the brainstem. (D) Immunohisto-
chemistry for HLA-DR, a major histocompatibility class II cell surface receptor, highlighted the leptomeningeal chronic inflammatory infil-
trates (arrow) and the mild-to-moderately increased brainstem microglial activation. 
 
ing therapies. A brain-restricted autopsy was per-
formed 7 days after death to aid in the determina-
tion of the etiology of the brain hemorrhage. 
Gross examination of the brain revealed a 
weight of 1280 grams, an enlarged left hemisphere, 
subfalcine left-to-right herniation of the left anterior 
frontal lobe and bilateral hippocampal uncal herni-
ations. Coronal sections confirmed a large ICH cen-
tered in the left frontal lobe in close proximity to the 
lateral ventricle with extension throughout the ven-
tricular system (Fig. 1B). Away from the hemor-
rhage, no additional gross pathological changes 
were identified. 
Microscopic examination revealed mild diffuse 
reactive changes (Fig. 1C and D) and focal 
periventricular lesions at the angles of the ventricles 
(Fig. 2). The diffuse reactive changes included rather 
mild leptomeningeal chronic inflammatory infil-
trates, parenchymal reactive gliosis and very mildly 
increased perivascular CD3 T-lymphocytes. The lep-
tomeningeal inflammatory infiltrates were com-
posed predominantly of macrophages and CD3 T-
cell lymphocytes found throughout the meninges, 
but were accentuated in the brainstem (Fig. 1C). Re-
active gliosis, highlighted by mild-to-moderately in-
creased immunoreactivity for human leukocyte anti-
gen – DR isotype (HLA-DR) and glial fibrillary acidic 
Free Neuropathology 2:7 (2021) Levine et al 





Figure 2. (A) Multifocal periventricular lesions showed loss of ependyma and significant infiltration by macrophages with scant accompa-
nying lymphocytes. (B) CD68 highlighted the significant macrophagic infiltrates. (C) Luxol-fast blue showed mild loss of myelin, while 
phosphorylated neurofilament (PNF) IHC (D) showed associated axonal pathology with significant numbers of axonal spheroids. 
 
protein (GFAP), was present predominantly in the 
brainstem and olfactory bulb. Similar changes were 
also seen in the younger individual. No microglial 
nodules were identified on hematoxylin and eosin 
(HE) stains. Two possible microglial nodules were 
identified on HLA-DR immunohistochemistry (IHC) 
in the medulla only.  
Atypical periventricular lesions (Fig. 2) were 
seen at multiple locations including both temporal 
horns, left occipital horn, fourth ventricle and in 
close proximity to the anterior left frontal lateral 
ventricle at the edge of acutely hemorrhagic brain 
parenchyma. These lesions consisted of loss of ep-
endymal lining, relatively well delimited macro-
phagic and lymphocytic infiltrates (Fig. 2A and B) 
and reactive vessels with plump endothelial cells. 
Axonal pathology, in the form of relatively frequent 
axonal spheroids without appreciable demye-
lination, was also present (Fig. 2C and D). Iron stains 
performed in several of these lesions were negative. 
The abundance of phagocytic macrophages and the 
absence of hemosiderin suggest that these lesions 
were older than the intracerebral hemorrhage and 
therefore not likely to be a reactive change to intra-
ventricular blood. This type of lesion was not seen in 
the younger individual, who instead exhibited multi-
focal petechial hemorrhages and microscopic is-
chemic infarcts thought to be most compatible with 
embolic lesions. No definite evidence of thrombi or 
megakaryocytes was identified in either of the 
cases. 
The neocortex, hippocampi, deep grey nuclei 
and cerebellum were unremarkable aside from 
some mild age-related neurodegenerative pathol-
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ogy. Pontine white matter tracts only showed sev-
eral microscopic foci of amyloid precursor protein 
(APP) immunoreactive axonal pathology associated 
with micro- and astrogliosis. CD68 revealed absence 
of mature phagocytic macrophages in these lesions. 
These were interpreted as foci of axonal damage 
secondary to traction due to the left frontal and in-
traventricular ICH. No cerebral amyloid angiopathy, 
arteriolosclerosis, lacunar infarcts or other vascular 
changes were identified. 
Polymerase chain reaction (PCR) test for the 
presence of SARS-CoV-2 RNA in multiple sections 
(medulla, hippocampus and olfactory bulbs) of for-
malin-fixed paraffin-embedded (FFPE) brain tissue 
was negative, including representation of the 
periventricular lesions. Similar results were ob-
tained for the younger patient. 
Discussion 
Our cases showed three main pathological 
changes: (1) acute and fatal ICH, (2) diffuse reactive 
changes and (3) additional parenchymal lesions, ei-
ther as multifocal chronic periventricular lesions in 
the elderly individual or as multifocal microhemor-
rhages and infarcts in the younger patient. The his-
topathological features of the periventricular lesions 
make them most compatible with localized tissue 
necrosis of unclear etiology. They were negative for 
SARS-CoV-2 RNA. To our knowledge, this type of le-
sion has not been studied extensively. A single re-
port comparing the neuropathological substrate of 
periventricular white matter abnormalities in pa-
tients with major depression and in controls de-
scribes lesions with similar characteristics to those 
found in this case. These lesions were interpreted as 
corresponding most likely to ischemic insults and 
were found both in a patient with major depression 
and a control11. The pathogenesis of these lesions 
awaits further evaluation, but the fact that lesions 
similar to those seen in our older individual have 
been described in non-COVID cases raises the possi-
bility that they are either nonspecific in etiology (e.g. 
associated with an episode of severe systemic ill-
ness) and/or can be brought about by different in-
jury mechanisms. Furthermore, in our case, it is un-
clear whether these lesions predated the SARS-CoV-
2 infection or developed as a consequence of it. 
The close relationship of the acute left frontal 
ICH to changes suggestive of an underlying 
periventricular lesion raise the possibility that local 
loss of tissue integrity may play a predisposing role 
to ICH in COVID-19. A similar situation was observed 
in the younger individual, in whom multifocal pete-
chial hemorrhages and microscopic ischemic in-
farcts were identified. These were interpreted as 
most likely due to microemboli in the context of se-
vere COVID-19 and therapeutic anticoagulation for 
extracorporeal membrane oxygenation (ECMO). 
Both patients were locally or systemically anti-
coagulated for therapeutic reasons and the risk of 
ICH in the setting of anticoagulation appears to be 
increased in patients with COVID-19. A study of 10 
patients with COVID-19 supported on ECMO for 
acute respiratory distress syndrome (ARDS) showed 
a markedly increased incidence of hemorrhagic 
strokes compared to non-COVID patients on 
ECMO12. 
The diffuse reactive changes identified in both 
COVID cases are similar to those reported previously 
in the literature and are at least partially explained 
as a manifestation of severe illness-related enceph-
alopathy5–7. Several tissue blocks of both cases were 
tested for SARS-CoV-2 by PCR and were negative. 
Neither patient received antiviral therapies that 
could have decreased SARS-CoV-2 tissue levels. For-
malin-fixed control lung tissue from an unrelated 
COVID-19 autopsy case with a shorter postmortem 
interval served as a positive control. Although the 
long post-mortem interval and formalin-fixation 
may have interfered with the detection of SARS-
CoV-2 in our samples, these results are in line with 
previously published reports that have shown incon-
sistent and variable detection of SARS-CoV-2 in brain 
parenchyma by PCR and immunohistochemical 
methods7,8. Overall, this would suggest that the 
brain is not a site consistently affected by high viral 
loads of SARS-CoV-2 and raises the possibility that 
direct infection of the CNS tissue may not be the 
main pathogenic mechanism of COVID-19 neuro-
logic manifestations. 
In summary, the fatal ICH in two cases of 
COVID-19 were most likely due to a combination of 
anticoagulation and additional factors affecting the 
integrity of the CNS parenchyma. Additional chronic 
inflammatory infiltrates and glial reactive changes 
are at least partially explained by severe illness-re-
lated encephalopathy. 
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